What is NDC 66267-377?

66267-377 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by NuCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

NuCare Pharmaceuticals, Inc., NDC labeler code 66267. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxazosin?

106 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxazosin NDC 66267-377 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)66267-377Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66267-0377Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66267-377-30	6626703773066267037730	30 TABLET in 1 BOTTLE (66267-377-30)Marketed from Nov 9, 2016
66267-377-90	6626703779066267037790	90 TABLET in 1 BOTTLE (66267-377-90)Marketed from Nov 9, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxazosin
Generic name (nonproprietary): doxazosin
Active ingredients: Doxazosin mesylate — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NuCare Pharmaceuticals, Inc.NDC labeler code 66267
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202824
Marketing start: Apr 22, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 66267-377_1fa6ba1c-3f81-2089-e063-6294a90a11c7SPL ID 1fa6ba1c-3f81-2089-e063-6294a90a11c7SPL set ID 40e47e75-6a47-323b-e054-00144ff8d46cRxCUI 197627UNII 86P6PQK0MUUPC 0366267377300
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466267037730 followed by a unit qualifier and the quantity

Package 66267-0377-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 14, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. Benign Prostatic Hyperplasia (BPH) Doxazosin tablets USP are indicated for the treatment of both the urinary outflow obstruction and obstructive and irritative symptoms associated with BPH: obstructive symptoms (hesitation, intermittency, dribbling, weak urinary stream, incomplete emptying of the bladder) and irritative symptoms (nocturia, daytime frequency, urgency, burning). Doxazosin tablets USP may be used in all BPH patients whether hypertensive or normotensive. In patients with hypertension and BPH, both conditions were effectively treated with doxazosin tablets USP monotherapy. Doxazosin tablets USP provide rapid improvement in symptoms and urinary flow rate i…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66267-377

What is NDC 66267-377?: 66267-377 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by NuCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxazosin.
What is the active ingredient?: Doxazosin mesylate.
Who is the labeler?: NuCare Pharmaceuticals, Inc., NDC labeler code 66267. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin?: 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-166	16571-0166-01
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-165	16571-0165-01
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-167	16571-0167-01
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-168	16571-0168-01
Doxazosindoxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Aurobindo Pharma Limited	59651-892	59651-0892-0159651-0892-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Aurobindo Pharma Limited	59651-893	59651-0893-0159651-0893-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aurobindo Pharma Limited	59651-894	59651-0894-0159651-0894-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Aurobindo Pharma Limited	59651-895	59651-0895-0159651-0895-99
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4031	70518-4031-00
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-3965	70518-3965-0070518-3965-01

All 107 Doxazosin NDCs

Other NDCs under ANDA 202824

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202824
Product	Strength	Form · route	Labeler	Product NDC
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Accord Healthcare Inc.	16729-211
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Accord Healthcare Inc.	16729-213
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Accord Healthcare Inc.	16729-414
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Accord Healthcare Inc.	16729-415
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	A-S Medication Solutions	50090-2153
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	A-S Medication Solutions	50090-2172
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	A-S Medication Solutions	50090-5773
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Northwind Health Company, LLC	51655-109
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Bryant Ranch Prepack	63629-7891
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-4272
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-4273
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-1560
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Proficient Rx LP	71205-690
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Bryant Ranch Prepack	71335-0309
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Bryant Ranch Prepack	71335-0349
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	direct rx	72189-117